• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $APM

    Aptorum Group Limited

    Subscribe to $APM
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

    IPO Year: 2018

    Exchange: NASDAQ

    Website: aptorumgroup.com

    Recent Analyst Ratings for Aptorum Group Limited

    DatePrice TargetRatingAnalyst
    See more ratings

    Aptorum Group Limited SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aptorum Group Limited

      SCHEDULE 13G/A - Aptorum Group Ltd (0001734005) (Subject)

      5/15/25 7:10:38 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 20-F filed by Aptorum Group Limited

      20-F - Aptorum Group Ltd (0001734005) (Filer)

      4/30/25 4:34:57 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Aptorum Group Limited

      6-K - Aptorum Group Ltd (0001734005) (Filer)

      4/16/25 4:01:12 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SCHEDULE 13G filed by Aptorum Group Limited

      SCHEDULE 13G - Aptorum Group Ltd (0001734005) (Subject)

      1/10/25 4:15:38 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Aptorum Group Limited

      6-K - Aptorum Group Ltd (0001734005) (Filer)

      1/7/25 6:06:33 AM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SCHEDULE 13G filed by Aptorum Group Limited

      SCHEDULE 13G - Aptorum Group Ltd (0001734005) (Subject)

      1/6/25 4:13:37 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Aptorum Group Limited

      424B5 - Aptorum Group Ltd (0001734005) (Filer)

      1/3/25 12:31:47 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Aptorum Group Limited

      6-K - Aptorum Group Ltd (0001734005) (Filer)

      12/20/24 4:00:38 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Aptorum Group Limited

      6-K - Aptorum Group Ltd (0001734005) (Filer)

      11/8/24 4:30:11 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Aptorum Group Limited

      6-K - Aptorum Group Ltd (0001734005) (Filer)

      11/1/24 4:30:02 PM ET
      $APM
      Biotechnology: Pharmaceutical Preparations
      Health Care